Social Affairs, Science and Technology – October 2, 2014

In Committee from the Senate of Canada

Social Affairs, Science and Technology – October 2, 2014

Senators continue their examination of Bill C-17, which is known as Vanessa’s Law in honour of Conservative MP Terence Young’s 15-year-old daughter, who died in 2000 of a heart attack caused by a prescription drug that later was deemed unsafe and removed from the market. The proposed legislation seeks to strengthen Canada’s drug-monitoring system. Canadian Pharmacists Association representatives Perry Eisenschmid (CEO) and Janet Cooper (vice president, professional and membership affairs) along with Bill Tholl (president and CEO) and Myrella Roy (executive director, Canadian Society of Hospital Pharmacists) of HealthCareCAN outline their respective organizations, express their overall support of the bill, but provide a few suggestions to improve it. Jamie Meuser (executive director, continuing professional development and practice support) of the College of Family Physicians of Canada and Robert Peterson (executive director, drug safety and effectiveness network) from the Canadian Institutes of Health Research provide additional support for the bill. (October 2, 2014)